Gregory Riedlinger

3.3k citations

54 papers · 1.9k indexed · 1 hit paper · h-index 22

Impact in

Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Cancer Research 20
- Cancer Genomics and Diagnostics 15
Oncology 15
- Cytokine Signaling Pathways and Interactions 5

Co-authors: Lothar Hennighausen (8 shared papers)Keiko Miyoshi (3 shared papers)Yongzhi Cui (2 shared papers)Gertraud W. Robinson (2 shared papers)Chu‐Xia Deng (1 shared paper)Wei Tang (1 shared paper)Cuiling Li (1 shared paper)Shridar Ganesan (20 shared papers)
Journals: Journal of Clinical Oncology (5 papers)JCO Precision Oncology (4 papers)Journal of Pathology Informatics (4 papers)BMC Cancer (3 papers)Hepatology (2 papers)
Partner nations: United States Japan Netherlands

In The Last Decade

Gregory Riedlinger

53 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers 2021 · 196 citations

Peers

Countries citing papers authored by Gregory Riedlinger

Since Specialization

Citations

This map shows the geographic impact of Gregory Riedlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Riedlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Riedlinger more than expected).

Fields of papers citing papers by Gregory Riedlinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Riedlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Riedlinger. The network helps show where Gregory Riedlinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory Riedlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory Riedlinger Line = papers co-authored together Gregory Riedlinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inactivation of Stat5 in Mouse Mammary Epithelium during Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation Molecular and Cellular Biology ·Yongzhi Cui, Gregory Riedlinger, Keiko Miyoshi, Wei Tang, Cuiling Li, Chu‐Xia Deng, Gertraud W. Robinson, Lothar Hennighausen	2004	406
2	Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers ESMO Open ·Matteo Palmeri, Janice M. Mehnert, Ann W. Silk, Salma K. Jabbour, Shridar Ganesan, Pallvi Popli, Gregory Riedlinger, Ryan D. Stephenson, Alexandre Buckley de Meritens, Aliza Leiser, Tina Mayer, Nancy Chan, Kristen Spencer, Eugenia Girda, Jyoti Malhotra, Timothy A. Chan, Vivek Subbiah, Roman Groisberg Hit paper breakdown →	2021	196
3	Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly Development ·Kay‐Uwe Wagner, Estefanı́a Claudio, Edmund B. Rucker, Gregory Riedlinger, Christine Broussard, Pamela L. Schwartzberg, Ulrich Siebenlist, Lothar Hennighausen	2000	171
4	Transferable anticancer innate immunity in spontaneous regression/complete resistance mice Proceedings of the National Academy of Sciences ·Amy M. Hicks, Gregory Riedlinger, Mark C. Willingham, Martha A. Alexander‐Miller, C. Von Kap-Herr, Mark J. Pettenati, Anne M. Sanders, Holly M. Weir, Wei Du, Joseph W. Kim, Andrew J.G. Simpson, Lloyd J. Old, Zheng Cui	2006	132
5	Endogenous retrovirus expression is associated with response to immune checkpoint pathway in clear cell renal cell carcinoma JCI Insight ·Anshuman Panda, Aguirre A. de Cubas, Mark N. Stein, Gregory Riedlinger, Joshua Kra, Tina Mayer, Christof C. Smith, Benjamin G. Vincent, Jonathan S. Serody, Kathryn E. Beckermann, Shridar Ganesan, Gyan Bhanot, W. Kimryn Rathmell	2018	118
6	Tsg101 Is Essential for Cell Growth, Proliferation, and Cell Survival of Embryonic and Adult Tissues Molecular and Cellular Biology ·Kay‐Uwe Wagner, Andrea Krempler, Yongyue Qi, Kyung-Ran Park, MaLinda D. Henry, Aleata A. Triplett, Gregory Riedlinger, Edmund B. Rucker, Lothar Hennighausen	2002	113
7	Outcomes of Patients With Esophageal Cancer Staged With [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection? Journal of Clinical Oncology ·Arta M. Monjazeb, Gregory Riedlinger, Mebea Aklilu, Kim R. Geisinger, Girish Mishra, Scott Isom, Paige B. Clark, Edward A. Levine, A. William Blackstock	2010	86
8	Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors Cell Reports ·Anchal Sharma, Elise Merritt, Xiaoju Hu, Angelique Cruz, Chuan Jiang, Halle Sarkodie, Zhan Zhou, Jyoti Malhotra, Gregory Riedlinger, Subhajyoti De	2019	79
9	Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine Frontiers in Oncology ·Katherine M. Morgan, Gregory Riedlinger, Jeffrey Rosenfeld, Shridar Ganesan, Sharon R. Pine	2017	57
10	Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC) Cancer Treatment and Research Communications ·Jyoti Malhotra, Salma K. Jabbour, Michelle Orlick, Gregory Riedlinger, Yanxiang Guo, Eileen White, Joseph Aisner	2019	52
11	Structure of the Mouse Stat 3/5 Locus: Evolution from Drosophila to Zebrafish to Mouse Genomics ·Keiko Miyoshi, Yongzhi Cui, Gregory Riedlinger, Phyllis R. Robinson, Jessica A. Lehoczky, Leonard I. Zon, Takami Oka, Ken Dewar, Lothar Hennighausen	2001	51
12	The liver-specific tumor suppressor STAT5 controls expression of the reactive oxygen species-generating enzyme NOX4 and the proapoptotic proteins PUMA and BIM in mice Hepatology ·Ji Hoon Yu, Bing‐Mei Zhu, Gregory Riedlinger, Keunsoo Kang, Lothar Hennighausen	2012	40
13	Aspergillus tanneri sp. nov., a New Pathogen That Causes Invasive Disease Refractory to Antifungal Therapy Journal of Clinical Microbiology ·Janyce A. Sugui, Stephen W. Peterson, Lily P. Clark, Glenn Nardone, Les Folio, Gregory Riedlinger, Christa S. Zerbe, Yvonne R. Shea, Christina Henderson, Adrian M. Zelazny, Steven M. Holland, Kyung J. Kwon‐Chung	2012	39
14	The Transcription Factors Signal Transducer and Activator of Transcription 5A (STAT5A) and STAT5B Negatively Regulate Cell Proliferation Through the Activation of Cyclin-Dependent Kinase Inhibitor 2b ( Cdkn2b ) and Cdkn1a Expression Hepatology ·Ji Hoon Yu, Bing‐Mei Zhu, Mark Wickre, Gregory Riedlinger, Weiping Chen, Atsushi Hosui, Gertraud W. Robinson, Lothar Hennighausen	2010	35
15	Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid‐stimulating hormone receptor gene mutations Diagnostic Cytopathology ·Sann Yu Mon, Gregory Riedlinger, Collette E. Abbott, Raja R. Seethala, N. Paul Ohori, Marina N. Nikiforova, Yuri E. Nikiforov, Steven P. Hodak	2018	28
16	Roadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in Oncology Cancer Informatics ·David J. Foran, Wenjin Chen, Huiqi Chu, Evita Sadimin, Doreen Loh, Gregory Riedlinger, Lauri Goodell, Shridar Ganesan, Kim M. Hirshfield, Lorna Rodriguez, Robert S. DiPaola	2017	27
17	Joint Segmentation and Fine-Grained Classification of Nuclei in Histopathology Images Hui Qu, Gregory Riedlinger, Pengxiang Wu, Qiaoying Huang, Jingru Yi, Subhajyoti De, Dimitris Metaxas	2019	27
18	Text Mining in Cancer Gene and Pathway Prioritization Cancer Informatics ·Yuan Luo, Gregory Riedlinger, Peter Szolovits	2014	26
19	Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers Gynecologic Oncology ·Lorna Rodríguez-Rodríguez, Kim M. Hirshfield, Verónica Rojas, Robert S. DiPaola, Darlene Gibbon, Mira Hellmann, Sara Isani, Aliza Leiser, Gregory Riedlinger, Allison Wagreich, Siraj M. Ali, Julia A. Elvin, Vincent A. Miller, Shridar Ganesan	2016	25
20	Bcl-x Is Not Required for Maintenance of Follicles and Corpus Luteum in the Postnatal Mouse Ovary1 Biology of Reproduction ·Gregory Riedlinger, Ryugo Okagaki, Kay‐Uwe Wagner, Edmund B. Rucker, Takami Oka, Keiko Miyoshi, Jodi A. Flaws, Lothar Hennighausen	2002	23

About Gregory Riedlinger

Gregory Riedlinger is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Immunology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), AI in cancer detection (8 papers), Cytokine Signaling Pathways and Interactions (5 papers), Genetic factors in colorectal cancer (5 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Biomedical Text Mining and Ontologies (4 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). The work is most often cited by research in Oncology (749 citations), Cancer Research (380 citations), Immunology (453 citations), Molecular Biology (728 citations) and Pulmonary and Respiratory Medicine (321 citations). Gregory Riedlinger has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include Lothar Hennighausen, Keiko Miyoshi, Yongzhi Cui, Gertraud W. Robinson, Chu‐Xia Deng, Wei Tang, Cuiling Li, Shridar Ganesan, Kay‐Uwe Wagner and Edmund B. Rucker. Their work appears in journals such as Journal of Clinical Oncology, JCO Precision Oncology, Journal of Pathology Informatics, BMC Cancer and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact